About
The Renishaw neuromate® is a CE-marked stereotactic robotic platform designed specifically for neurosurgery. Developed by Renishaw — a global leader in precision measurement and motion control — the neuromate provides neurosurgeons with an accurate, consistent, and repeatable tool for minimally invasive brain procedures. The robot supports a broad spectrum of neurosurgical applications, including stereoelectroencephalography (SEEG) for epilepsy mapping, deep brain stimulation (DBS) electrode implantation, stereotactic biopsy for tissue sampling, and neuro-endoscopy procedures. By automating trajectory planning and instrument positioning, it significantly reduces the risk of human error and improves the reproducibility of complex interventions. Key advantages include faster procedure times compared to traditional frame-based stereotaxy, improved targeting accuracy, and seamless integration with neuronavigation and imaging workflows. The system is designed to work within operating room environments and is compatible with standard intraoperative imaging protocols. The neuromate is intended for use in hospitals and neurosurgical centers where precision and efficiency are paramount. It is particularly valuable in epilepsy surgery programs, movement disorder clinics performing DBS, and oncology units requiring stereotactic biopsy. With a strong track record in clinical use across Europe and beyond, the neuromate represents a trusted choice for institutions seeking to elevate the quality and consistency of their neurosurgical practice.
Key Features
- Multi-Procedure Support: Supports a wide range of neurosurgical applications including SEEG, DBS, stereotactic biopsy, and neuro-endoscopy from a single robotic platform.
- High-Precision Targeting: Delivers consistent, accurate, and repeatable instrument positioning to meet the tight tolerances required in stereotactic neurosurgery.
- Reduced Human Error: Robotic guidance minimizes variability from manual targeting, improving safety and reproducibility across procedures.
- Faster Procedure Times: Automated trajectory execution reduces set-up and intraoperative time compared to traditional frame-based stereotactic techniques.
- Neuronavigation Integration: Integrates with intraoperative imaging and neuronavigation systems to support real-time surgical planning and execution.
Use Cases
- Epilepsy surgery centers performing SEEG implantation to map seizure onset zones with high spatial precision.
- Movement disorder clinics implanting DBS electrodes for Parkinson's disease and essential tremor treatment.
- Neurosurgical oncology units conducting stereotactic biopsies of deep-seated brain lesions.
- Neuro-endoscopy procedures requiring precise robotic guidance for instrument placement.
- Academic medical centers and teaching hospitals integrating robotic neurosurgery into their clinical and research workflows.
Pros
- Proven Clinical Accuracy: Renishaw's precision engineering heritage ensures the neuromate meets the strict accuracy demands of stereotactic neurosurgery.
- Broad Application Range: A single system covers multiple neurosurgical specialties, maximizing return on investment for surgical centers.
- Reduced Operative Time: Automated positioning and trajectory planning streamline workflows, benefiting both surgical teams and patients.
Cons
- High Capital Cost: As a specialized medical robotic system, the neuromate requires significant institutional investment and is not accessible to smaller facilities.
- Specialized Training Required: Surgical teams must undergo dedicated training to use the system safely and effectively, adding to implementation overhead.
- Limited to Neurosurgical Use Cases: The platform is purpose-built for neurosurgery and cannot be repurposed for other surgical or non-medical applications.
Frequently Asked Questions
The neuromate supports stereoelectroencephalography (SEEG), deep brain stimulation (DBS) electrode implantation, stereotactic biopsy, and neuro-endoscopy procedures.
The neuromate uses robotic positioning to execute pre-planned trajectories with high repeatability, reducing reliance on manual alignment and minimizing human error.
Yes, the neuromate is designed to integrate with intraoperative imaging and neuronavigation workflows commonly used in neurosurgical operating rooms.
The neuromate is manufactured by Renishaw plc, a UK-based global company with expertise in precision measurement, motion control, and healthcare technologies.
Renishaw offers standard and bespoke training courses for surgical teams. Proper training is required before clinical use to ensure safe and effective operation.